Healthcare professionals must therefore balance the substantial benefits of GLP-1 therapy against this potential, though uncommon, risk when prescribing these agents
Low back, hip, or glute: the upper outer glute on the affected side
While the appetite suppressive effects of amylin and GLP-1 receptor agonists are known to involve direct actions in the brain 6,7,9,10,12,13,14 , uncovering the neuroanatomical site(s) of action and the physiological mechanisms that mediate the anorectic response remains an area of intense research focus
In December 2024, Lilly announced another $3 billion to expand an existing plant in Kenosha County, Wisconsin ( [8] )
Predictions were made across observed dose ranges, and minimal effective doses were estimated based on both the upper bounds of 95% CIs and the predicted mean difference required to reach a clinically meaningful reduction